Tadalafil may be appropriate for some patients with stable cardiovascular disease, but several factors must be assessed first:
* Cardiac stability: Confirm that the patient’s heart failure is stable and that sexual activity is considered safe.
* Blood pressure: Tadalafil can lower blood pressure, potentially increasing the risk of dizziness, fainting, or symptomatic hypotension when combined with antihypertensive medications.
* Medication interactions: Tadalafil must not be combined with nitrate medications, such as nitroglycerin or isosorbide, or with riociguat. Caution is also needed with certain other medications.
*
Kidney and
liver function: These may affect tadalafil’s suitability and dosing.
*
Diabetes management: Diabetes can contribute to erectile dysfunction, so glucose control and other underlying causes should also be reviewed.
Recommendation: Obtain a medication review and cardiovascular assessment before initiating daily tadalafil. If the patient is clinically stable and his cardiologist considers treatment appropriate, a clinician can determine whether 5 mg daily is suitable.
If chest pain, severe breathlessness, fainting, or other acute cardiac symptoms occur, seek urgent medical attention. If chest pain occurs after taking tadalafil, do not self-administer nitrates; inform emergency personnel that tadalafil was taken.
Bottom line: Tadalafil 5 mg daily for one month is not automatically contraindicated by HFpEF, but its safety cannot be confirmed without knowing the patient’s cardiac stability, blood pressure, complete medication list, and renal function.